SINOVAC BIOTECH LTD (SVA) Shareholders’ equity 2016–2025
SINOVAC BIOTECH LTD (SVA) shareholders’ equity at each fiscal year-end, per SEC filings.
$4.4BFY2025 · since FY2016: $115.8M → $4.4B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $4.4B | -46.3% |
| FY2024 | $8.3B | -0.6% |
| FY2023 | $8.3B | -2.1% |
| FY2022 | $8.5B | -5.6% |
| FY2021 | $9.0B | +1105.0% |
| FY2020 | $746.5M | +153.9% |
| FY2019 | $294.0M | +16.0% |
| FY2018 | $253.4M | +67.7% |
| FY2017 | $151.2M | +30.6% |
| FY2016 | $115.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice